The AASM Case Study of the Month for June is about a 27-year-old man who presents to the clinic with complaints of unrefreshing sleep and daytime sleepiness despite making several changes to his sleep hygiene. The case was submitted by Anuj Behal, MD; [...]
Anita V. Shelgikar, MD, MHPE, became the president of the American Academy of Sleep Medicine (AASM) board of directors on Monday, June 9, 2025, during the AASM annual membership meeting, which took place in Seattle as part of the SLEEP 2025 annual meeting [...]
Eric J. Olson, MD, completed his term as president of the American Academy of Sleep Medicine (AASM) board of directors on Monday, June 9, 2025, during the AASM annual membership meeting, which took place in Seattle as part of the SLEEP 2025 annual [...]
DARIEN, IL – Today, Dr. Anita Shelgikar became the 40th president of the American Academy of Sleep Medicine board of directors. Shelgikar took the helm of the nation’s leading sleep medicine professional society during SLEEP 2025, the annual meeting of the Associated Professional [...]
DARIEN, IL – The American Academy of Sleep Medicine recently recognized four sleep centers for maintaining AASM accreditation for 40 continuous years, reflecting their long-standing dedication to providing high-quality care for people with sleep problems. The AASM honored these programs during SLEEP 2025, [...]
The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. SLEEP begins today: Register on-site! Rise and shine, Seattle! On-site registration begins at 7 a.m. today for SLEEP [...]
The Viatom Smart Ring Pulse Oximeter – O2Ring received FDA approval in February 2025. This wearable device measures pulse rate and blood oxygen saturation (SpO2) levels, and is designed for use in both clinical and home settings. About the O2Ring The Viatom Smart [...]
On June 5, 2025, Avadel Pharmaceuticals announced that the FDA granted orphan drug designation to Lumryz, its extended-release sodium oxybate medication, for the treatment of idiopathic hypersomnia (IH). The FDA’s orphan drug designation provides incentives for drugs and biologics for the treatment of rare [...]
The American Academy of Sleep Medicine congratulates Douglas E. Moul, MD, MPH, who was named the 2025 recipient of the Beacon Award for Excellence in Peer Review, which recognizes one individual whose contributions stand above all others for their work as a manuscript [...]
Whether you're looking to network, learn, or grow, membership is designed to provide maximum value and exclusive development. Now is a great time to join at a reduced rate for 2024 and experience the best that AASM has to offer! Starting June 1, prorated [...]